Bio


Dr. Kim’s focus is on international medicine. She is the Director of Educational Programs at the Stanford Center for Asian Healthcare Research and Education (CARE), and Medical Director of the International Medical Service (IMS) Department of Stanford Health Care. She was appointed to Harvard’s Global Health and Service Advisory Council, a body of individuals, thought leaders and leading Harvard faculty charged with providing a broad, real-world perspective on programs, and identifying new opportunities for growth and enhancement. Dr.Kim is also Chairman of the Chi-Li Pao Foundation USA, as well as a trustee of the Chi-Li Pao Foundation in Hong Kong, organizations committed to supporting educational and healthcare programs for the benefit of mankind. She was the founding Medical Director of the International Travel Medicine Service and was Chief of the Department of Internal Medicine at Hong Kong Adventist Hospital. She was previously a faculty member at UCLA, as well as a honorary and adjunct faculty member at the University of Hong Kong and the Chinese University of Hong Kong.

Clinical Focus


  • Internal Medicine

Academic Appointments


Administrative Appointments


  • Director, Educational Programs, Center for Asian Health Research and Education (CARE) (2019 - Present)
  • Medical Director, International Medical Services, Stanford Hospital (2011 - Present)

Honors & Awards


  • Member, Alpha Omega Alpha Honor Society (1983-present)

Boards, Advisory Committees, Professional Organizations


  • Advisor, ABC's for Global Health (2022 - Present)
  • Faculty Fellow, Center for Innovation in Global Health (CIGH) (2021 - Present)
  • Member, Global Health and Service Advisory Council, Harvard Medical School (2020 - Present)
  • Trustee, Chi-Li Pao Foundation, Hong Kong (2019 - Present)
  • Chairman, Chi-Li Pao Foundation, USA (2018 - Present)
  • Fellow, Hong Kong Academy of Medicine (1995 - Present)
  • Fellow, Hong Kong College of Physicians (1995 - Present)
  • Fellow, American College of Physicians (1992 - Present)
  • Diplomate, American Board of Internal Medicine (1986 - Present)

Professional Education


  • Chief Medical Resident, UCLA School of Medicine, Internal Medicine
  • Medical Resident, UCLA School of Medicine, Internal Medicine
  • Medical Intern, UCLA School of Medicine, Internal Medicine
  • Doctor of Medicine, UCLA School of Medicine
  • Bachelor of Science, Stanford University, Chemistry

Current Research and Scholarly Interests


Medical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction

All Publications


  • Characterizing patient-reported claudication treatment goals to support patient-centered treatment selection and measurement strategies. Journal of vascular surgery Powell, C. A., Kim, G. Y., Edwards, S. N., Aalami, O., Treat-Jacobson, D., Byrnes, M. E., Osborne, N. H., Corriere, M. A. 2022

    Abstract

    OBJECTIVE: Patient-reported outcomes (PRO) are increasingly emphasized for peripheral artery disease (PAD). Patient-defined treatment goals and expectations, however, are poorly understood and may not be achievable or aligned with guidelines or traditional outcomes. We evaluated patient-reported treatment goals among patients with claudication and associations between patient characteristics, goals, and PAD-specific PRO scores.METHODS: Patients diagnosed with claudication were prospectively recruited. Patient-defined treatment goals and outcomes related to walking distance, duration, and speed were quantified using multiple choice survey items. Free-text items were used to identify activities other than walking distance, duration or speed associated with PAD symptoms and treatment goals. The Peripheral Artery Disease Quality of Life (PADQOL) and Walking Impairment Questionnaire (WIQ) instruments were included as PRO. Treatment goal categories were compared with PRO percentile scores using confidence intervals, categorical tests, and logistic regression models. Associations between patient characteristics and PRO were evaluated using linear and ordinal logistic regression models.RESULTS: 150 patients meeting the inclusion criteria participated; of these, 144 (96%) viewed the entire survey. Mean age was 70.0±11.3 years, and 32.9% were women. The majority of respondents self-reported race as white (N=135), followed by Black (N=3), Asian (N=2), American Indian (N=2) and other/unknown (N=2). Two participants self-reported Hispanic ethnicity. Primary treatment goals were: increased walking distance or duration without stopping (62.0%), ability to perform a specific activity or task (23.0%), increased walking speed (8.0%), or other/none of the above (7.0%). Specific activities associated with symptoms or goals included: outdoor recreation (38.5%), labor-related tasks (30.7%), sports (26.9%), climbing stairs (23.1%), uphill walking (19.2%), and shopping (6%). Among patients choosing increased walking distance and duration as primary goals, 64% indicated a distance ≥0.5 miles (2640 feet) and 59% indicated a duration ≥ 30 minutes as minimum increases consistent with meaningful improvement. Increasing age was associated with lower odds of a distance improvement goal ≥ 0.5 miles (OR 0.68 per 5 years; 95% CL 0.51-0.92; P=0.012) or duration improvement goal ≥ 30 minutes (OR 0.76 per 5-years; 95% CL 0.58-0.99; P=0.047). Patient characteristics associated with PADQOL percentile scores included age, ABI, and gender. ABI was the only patient characteristic associated with WIQ percentile scores.CONCLUSIONS: Patients define treatment goals based on activities and expectations that may influence perceived outcomes. Minimum walking distance and duration increases consistent with meaningful improvement exceed published minimum important difference criteria for many patients and would be uncaptured using common clinic-based walking tests. Patient age is associated with both treatment goals and PRO scores, and related floor and ceiling effects may influence sensitivity to PRO change among older and younger patients. Heterogeneity in treatment goals supports consideration of tailored approaches informed by patient characteristics and perspectives regarding treatment success versus failure.

    View details for DOI 10.1016/j.jvs.2022.09.002

    View details for PubMedID 36087833

  • Vaccination patterns, disparities, and policy among Asian-Americans and Asians living in the USA. The Lancet. Global health Jamal, A., Wang, R., Wang, Z., Dan, S., Srinivasan, M., Kim, G., Palaniappan, L., Singh, J., Kappagoda, S. 2022; 10 Suppl 1: S27

    Abstract

    Although Asian-American individuals have higher rates of some vaccine-preventable diseases such as hepatitis B, vaccination rates among them are low compared with those of non-Hispanic White individuals. Most vaccine research looks at Asian-American people as a single category despite large within-group heterogeneity in health-seeking behaviours. Little is known about vaccination coverage among disaggregated Asian-American ethnic subgroups, although such information could inform policies focused on increasing vaccine uptake. Therefore, we aimed to assess vaccination coverage for several vaccines among disaggregated Asian-American subgroups.We examined National Health Interview Survey (NHIS) data from 2015-18 to analyse the vaccination status of Chinese, Asian Indian, Filipino, other Asian, and non-Hispanic White adults (n=253 626) for seven vaccines recommended by the US Centers for Disease Control and Prevention: human papillomavirus (HPV), hepatitis B (HBV), influenza, tetanus, tetanus-diphtheria-pertussis (Tdap), shingles, and the pneumococcal vaccine. We used NHIS data from 2006-18 (n=880 210) to analyse changes in vaccination rates for each ethnic group over time. We used logistic regression to estimate differences in vaccination rates while controlling for demographic, socioeconomic and health-related variables.Among the seven vaccines, HPV and shingles vaccines had the lowest uptake, whereas Tdap had the highest uptake among all groups. Compared with the non-Hispanic White group, Asian Indians were almost half as likely to receive the HPV vaccine (odds ratio 0·61, 95% CI 0·41-0·92), whereas Filipinos (1·51, 1·02-2·25) and other Asians (1·42, 1·02-1·97) were more likely to receive it. The Filipino (1·50, 1·21-1·88) and other Asian groups (1·42, 1·19-1·71) were more likely to receive the HBV vaccine than the non-Hispanic White group. For the influenza vaccine, the Asian Indian (1·28, 1·05-1·56), Filipino (1·44, 1·17-1·79) and other Asian (1·38, 1·16-1·65) groups were more likely to receive the vaccine than the non-Hispanic White group. For the pneumococcal vaccine, the Chinese (0·57, 0·34-0·94) and other Asian (0·66, 0·47-0·92) groups were less likely to receive the vaccine than the non-Hispanic White group.Among US adults, we found significant disparities in vaccine uptake among different Asian and Asian-American ethnic groups. US policy makers trying to improve vaccine uptake among Asian and Asian-American people could learn from successful international immunisation programmes to develop culturally appropriate interventions to improve vaccine uptake in Asian and Asian-American individuals.None.

    View details for DOI 10.1016/S2214-109X(22)00156-5

    View details for PubMedID 35362432

  • Vaccination patterns, disparities, and policy among Asian-Americans and Asians living in the USA Jamal, A., Wang, R., Wang, Z., Dan, S., Srinivasan, M., Kim, G., Palaniappan, L., Singh, J., Kappagoda, S. ELSEVIER SCI LTD. 2022: 27
  • Precision Public Health Matters: An International Assessment of Communication, Preparedness, and Coordination for Successful COVID-19 Responses. American journal of public health Sales, C., Kim, Y., Kim, G., Lin, B., Palaniappan, L. 2021; 111 (3): 392–94

    View details for DOI 10.2105/AJPH.2020.306129

    View details for PubMedID 33566659

  • Shifting our stance for current COVID-19 outbreaks: A global response to an international pandemic JOURNAL OF GLOBAL HEALTH Obra, J., Lin, B., Palaniappan, L., Kim, G. S. 2021; 11
  • Scuba Diving The Hong Kong Medical Diary Pei, G. K. 2009; 14 (9)
  • Western impressions of the Hong Kong health care system WESTERN JOURNAL OF MEDICINE Bennett, C. L., Pei, G. K., Ultmann, J. E. 1996; 165 (1-2): 37–42

    Abstract

    Hong Kong, Taiwan, Singapore, and Malaysia are initiating health care reform to meet the changing demands of populations with improved socioeconomic status and access to modern technologies and who are living longer than in previous generations. Hong Kong, in particular, is facing a unique set of circumstances as its people prepare for the transition in 1997 from a British colony to a Special Administrative Region of China. While spending only 4% of its gross domestic product on health care, it has a large and regulated public hospital system for most inpatient medical care and a separate, loosely regulated private health care system for most outpatient medical care. In 1993 the Secretary for Health and Welfare of Hong Kong initiated a year-long process to debate the pros and cons of 5 fundamental programs for health care reform. After a year of open consultation, options were chosen. We describe the Hong Kong health care system, the fundamental changes that have been adopted, and lessons for reformers in the United States.

    View details for Web of Science ID A1996VG80200005

    View details for PubMedID 8855683

    View details for PubMedCentralID PMC1307539

  • Doctor-shopping in Hong Kong: implications for quality of care. International journal for quality in health care : journal of the International Society for Quality in Health Care Lo, A. Y., Hedley, A. J., Pei, G. K., Ong, S. G., Ho, L. M., Fielding, R., Cheng, K. K., Daniel, L. 1994; 6 (4): 371-81

    Abstract

    Doctor-shopping is defined as the changing of doctors without professional referral in the same illness episode. Two surveys on samples of patients attending Government Out-Patient Departments (GOPDs) in Hong Kong in 1989 (n = 869) and 1990 (n = 901) estimated the prevalence of shopping at nearly 40%, the main reason being a persistence of symptoms. Doctor-shoppers were likely to be younger with higher expectations of health care and who expressed dissatisfaction about aspects of the present service. In Hong Kong, patients perceive western medicine to be more effective and have high expectations of the effects of western drugs, in particular, in their administration by injection. Patients should be warned about iatrogenic health risks incurred from doctor-shopping; health education programmes are needed to modify unrealistic views about quality care. Health care providers in a mixed care system should promote greater continuity of care between doctors and both the public and private sectors, and identify and resolve problems which may be responsible for discontinuity of care.

    View details for DOI 10.1093/intqhc/6.4.371

    View details for PubMedID 7719673

  • The Future Role Of Specially-Trained Nurses In The Delivery Of Primary Health Care In Hong Kong Hong Kong Practitioner Pei, G. K., Hedley, A. J. 1994; 14 (1): 1-10
  • The health and health care choices of women in Hong Kong Hong Kong Practitioner Pei, G. K., Cheng, K. K., Hedley, A. J. 1991; 13 (10): 1714-1728
  • Preventive health measures and counseling in the government outpatient department clinics Hong Kong Practitioner Pei, G. K., Hedley, A. J., Cheng, K. K., Lo, A., Fielding, R. 1991; 13 (12): 1838-1853